Become a digitalPLUS subscriber. 99 for 4 weeks.

Topics

Otis Brawley
Targeted breast cancer therapies coming to the forefront in treatment
Targeted breast cancer therapies coming to the forefront in treatment

If there ever was a right time to be diagnosed with breast cancer, Beth Thompson found one. In February 2006, the pea-size tumor in her right breast was too small for a clinical trial of Herceptin, a targeted therapy that had proved effective in advanced stages of the aggressive cancer Thompson had. She underwent a lumpectomy and chemotherapy. When the cancer continued to show signs of growth, she had a double mastectomy. But soon after, her doctor, buoyed by promising trial results, encouraged her to consider Herceptin, developed by Genetech to target the protein that fuels the cancer's growth. Six years later, Thompson, now 47, is in remission and so healthy that she takes no...

Loading